CompletedNot Applicable

MAnagement of METastatic Disease in Campania (MAMETIC)

Italy3,234 participantsStarted 2020-09-11

Plain-language summary

The MAMETIC Trial represents the first regional epidemiological study that aims to evaluate patients living in Campania with metastatic cancer, with the intent to detect different prevalence of tumors in the metastatic phase and evaluate the local response to the patient's request for assistance. Condition or disease: Metastatic disease Intervention/treatment: Radiation Treatment

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged \> 18 years resident in Campania Region; * Patients diagnosed with metastatic disease candidates for radiotherapy * Metastatic patients candidates for radiotherapy re-treatment * Oligometastatic patients candidates for radiotherapy; Patients who have given their consent Exclusion Criteria: * Patients aged \< 18 years * Patients who are unable to express consent to sensitive data and radiant treatment

What they're measuring

Retrospective Study: Occurrence of palliative radiotherapy treatments in the Campania region

Timeframe: 20 months (Interval from January 2019 to August 2020)

Prospective Study: Occurrence of palliative radiotherapy treatments in the Campania region

Timeframe: 60 months (Interval from September 2020 to September 2025)

Trial details

NCT IDNCT04595032

SponsorNational Cancer Institute, Naples

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-02-08

View on ClinicalTrials.gov More Metastatic Disease trials